Article
Pro32Thr polymorphism of inosine triphosphate pyrophosphatase gene predicts efficacy of low-dose azathioprine for patients with systemic lupus erythematosus.
Clinical pharmacology and therapeutics - 1 May 2009
Okada Y, Nakamura K, Hiromura K, Nojima Y, Horiuchi R, Yamamoto K
Abstract excerpt
We evaluated the relationship between the efficacy of low-dose azathioprine (AZA) therapy and the inosine triphosphate pyrophosphatase (ITPA) 94C>A (Pro32Thr) polymorphism in patients with systemic lupus erythematosus (SLE). We performed a multiple regression analysis to assess the influence of various factors on the reduction in SLE disease activity index (SLEDAI) scores. The ITPA 94C>A polymorphism had the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
